Status
Conditions
Treatments
About
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
Full description
The proposed study is a cross sectional study that will be carried out among HCWs in three University hospitals namely Kasr Alaini , Ain Shams , and Zagazeg Hospitals, employing a quantitative survey.
II-Study population Participants will be the HCWs at great risk of getting an infection which include those who are in direct contact with respiratory secretions.
Inclusion criteria Age: From 25 to 60 years old Department: physicians and nurses from the operating room, critical care department, emergency department, pulmonology department.
The potential participants will be given an information sheet and time to review this information before informed consent is sought. After the potential participants have agreed to be enrolled in the study, an informed consent will be obtained by the Investigator.
III- Procedures and Data collection:
Serum Collection and Interview A- Detecting Serum IgG against SARS-CoV2
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization.(5) The sensitivity and specificity reported by the manufacturer for IgM are 88.2% and 99.0% respectively, and for IgG are 97.8% and 97.9%.
B- Structured Interview questionnaire
A structured - interview questionnaire using closed ended question format will be used to obtain information on:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal